Multidisciplinary approach to patient care in Ontario, California

California Neuropsychiatric Institute, located at 3400 Inland Empire Boulevard in Ontario, California, is a leading institution specializing in personalized care to optimize outcomes and improve quality of life for patients. The institute offers a multidisciplinary approach incorporating biological, psychosocial, and cultural treatment practices recommended by CEO Dr. Hassamal, an active research investigator with extensive experience in cutting-edge pharmacotherapeutics, digital technologies, and neuromodulation treatments. The institute focuses on addressing dysfunction in brain circuits that underlie the evolution and progression of neuropsychiatric disorders, often recommending neuromodulation therapies to restore brain circuitry function. Dr. Hassamal's research has also identified potential anti-inflammatory treatment pathways to address neuroinflammation, with commonly prescribed medications including anti-inflammatories, hypoglycemic medications, cholesterol-lowering agents, and anti-obesity pharmacotherapies to reduce inflammation and improve overall brain health.